MCT is proud to be successfully running a Polio Vaccine study with 1,119 patients randomized within 5 months and targeting around 3,000 patients by March 2022.
MCT would like to congratulate Dr Jahanjir Hossain and his team for completing the first cohort of the study.
MCT Insights – Perspectives on issues that are reshaping Clinical Research in Middle East and Africa : Plan to make HCV disappear in Egypt
MCT attended PCMG 2020 live on June 24-26. This was an opportunity to experience remote conference on Zoom and like for previous conferences to exchange with outsourcing and procurement professionals working in R&D across Pharma industry.
MCT attended the 2019 Clinical Research Forum organized by the Ministry of Health and Prevention, United Arab Emirates.
Updates about the status of clinical research in GCC countries, health policies and regulations were presented.
MCT inaugurates on 1-Nov-19 its new office in Jordan
MCT was honored to take part to the 16th CardioVascular Clinical Trialist forum held in Cairo on September 19th and 20th in presence of highly qualified panel from Europe, MEA and USA who discussed the experience of the MEA region in Clinical Trials and shared their insights about how to become more attractive. Regulators and industry shared their common objectives while focusing on improving the patient experience when participating to clinical trial.
Aymen Garalli, MCT Country Manager for Tunisia had the opportunity to share his view on Literacy, Language and cultural issues with consenting procedures on the region.
MCT team meets Tunisian health Minister to discuss development of clinical research in Tunisia on July 15th 2019.